These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
998 related articles for article (PubMed ID: 28160999)
1. [The "immune checkpoints", how does it work]. Granier C; Soumelis V; Mandavit M; Gibault L; Belazzoug R; de Guillebon E; Badoual C; Tartour E; Roussel H Ann Pathol; 2017 Feb; 37(1):18-28. PubMed ID: 28160999 [TBL] [Abstract][Full Text] [Related]
2. T cell checkpoint regulators in the heart. Grabie N; Lichtman AH; Padera R Cardiovasc Res; 2019 Apr; 115(5):869-877. PubMed ID: 30721928 [TBL] [Abstract][Full Text] [Related]
3. [Predictive biomarkers of efficacy of checkpoint blockade inhibitors in cancer treatment]. Duruisseaux M; Lize-Dufranc C; Badoual C; Bibeau F Ann Pathol; 2017 Feb; 37(1):46-54. PubMed ID: 28131419 [TBL] [Abstract][Full Text] [Related]
5. Can Immunogenic Chemotherapies Relieve Cancer Cell Resistance to Immune Checkpoint Inhibitors? Rivera Vargas T; Apetoh L Front Immunol; 2019; 10():1181. PubMed ID: 31191545 [TBL] [Abstract][Full Text] [Related]
6. Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors. Hargadon KM; Johnson CE; Williams CJ Int Immunopharmacol; 2018 Sep; 62():29-39. PubMed ID: 29990692 [TBL] [Abstract][Full Text] [Related]
7. [Toxicity of immune checkpoints inhibitors]. Delaunay M; Caron P; Sibaud V; Godillot C; Collot S; Milia J; Prévot G; Mazières J Rev Mal Respir; 2018 Dec; 35(10):1028-1038. PubMed ID: 30213624 [TBL] [Abstract][Full Text] [Related]
8. Checkpoint inhibitors in AML: are we there yet? Ghosh A; Barba P; Perales MA Br J Haematol; 2020 Jan; 188(1):159-167. PubMed ID: 31808941 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of immune checkpoint blockade for brain metastases. Harary M; Reardon DA; Iorgulescu JB CNS Oncol; 2019 Jun; 8(2):CNS33. PubMed ID: 30854898 [No Abstract] [Full Text] [Related]
11. [Current events in immunotherapy for upper aerodigestive tract cancer]. Outh-Gauer S; Le Tourneau C; Broudin C; Scotte F; Roussel H; Hans S; Mandavit M; Tartour E; Badoual C Ann Pathol; 2017 Feb; 37(1):79-89. PubMed ID: 28111039 [TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory role for MicroRNAs: Regulation of PD-1/PD-L1 and CTLA-4 immune checkpoints expression. Skafi N; Fayyad-Kazan M; Badran B Gene; 2020 Sep; 754():144888. PubMed ID: 32544493 [TBL] [Abstract][Full Text] [Related]
13. Recent advances in the clinical development of immune checkpoint blockade therapy. Ghahremanloo A; Soltani A; Modaresi SMS; Hashemy SI Cell Oncol (Dordr); 2019 Oct; 42(5):609-626. PubMed ID: 31201647 [TBL] [Abstract][Full Text] [Related]
14. Checkpoint inhibitors in hematological malignancies. Ok CY; Young KH J Hematol Oncol; 2017 May; 10(1):103. PubMed ID: 28482851 [TBL] [Abstract][Full Text] [Related]